You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 4, April 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic

Chronic Parkinsonism Associated With Cirrhosis

A Distinct Subset of Acquired Hepatocerebral Degeneration

Pierre R. Burkhard, MD; Jacqueline Delavelle, MD; Renaud Du Pasquier, MD; Laurent Spahr, MD

Arch Neurol. 2003;60:521-528.

Context  The clinical, neuroradiological, and biological characteristics of the so-called acquired hepatocerebral degeneration have not yet been fully determined and its frequency remains largely uncertain.

Objectives  To prospectively study the prevalence of extrapyramidal symptoms in patients with moderate to severe cirrhosis of various causes, to delineate the main neurological features of the condition, and to establish correlations with neuroradiological and biological findings.

Patients and Methods  During a 1-year period, all consecutive patients with cirrhosis who were potential candidates for liver transplantation were screened for extrapyramidal features. When extrapyramidal features were present, further workup included a detailed neurological examination, magnetic resonance imaging of the brain, a comprehensive battery of neuropsychological tests, extensive blood tests, and, in some cases, cerebrospinal fluid analysis.

Setting  A community-based hospital.

Results  From 51 patients screened, 11 (21.6%) exhibited moderate to severe parkinsonism sometimes associated with focal dystonia. Typical features included rapid progression over months, symmetric akinetic-rigid syndrome, postural but not resting tremor, and early postural and gait impairment. Neuropsychiatric manifestations were minimal. Some patients were responsive to levodopa therapy. In all patients, magnetic resonance imaging scans showed striking hyperintensities on T1-weighted images typically involving the substantia nigra and the globus pallidus bilaterally. Whole blood and cerebrospinal fluid manganese concentrations were severalfold above the reference range.

Conclusions  Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes. This form of parkinsonism can be clearly distinguished from other forms of parkinsonism of middle to advanced age, based on a suggestive association of clinical, neuroradiological, and biological abnormalities. Our findings support the concept of the toxic effects of manganese being the major determinant of basal ganglia dysfunction leading to the predominantly extrapyramidal central nervous system manifestations of cirrhosis observed in these patients.


From the Departments of Neurology (Drs Burkhard and Du Pasquier), Neuroradiology (Dr Delavelle), and Gastroenterology and Hepatology (Dr Spahr), University Hospital, Geneva, Switzerland.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
Stepens et al.
NEJM 2008;358:1009-1017.
ABSTRACT | FULL TEXT  

Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity
Klos et al.
Neurology 2006;67:1984-1989.
ABSTRACT | FULL TEXT  

Evidence for Cortical Dysfunction and Widespread Manganese Accumulation in the Nonhuman Primate Brain following Chronic Manganese Exposure: A 1H-MRS and MRI Study
Guilarte et al.
Toxicol Sci 2006;94:351-358.
ABSTRACT | FULL TEXT  

Occupational manganese neurotoxicity provoked by hepatitis C.
Schaumburg et al.
Neurology 2006;67:322-323.
ABSTRACT | FULL TEXT  

An Overview of Psychiatric Issues in Liver Disease for the Consultation-Liaison Psychiatrist
Crone et al.
Psychosomatics 2006;47:188-205.
ABSTRACT | FULL TEXT  

Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging: Probable Manganese Neurotoxicity
Klos et al.
Arch Neurol 2005;62:1385-1390.
ABSTRACT | FULL TEXT  

Searching for a relationship between manganese and welding and Parkinson's disease
Jankovic
Neurology 2005;64:2021-2028.
ABSTRACT | FULL TEXT  

A Novel Isoform of the Secretory Pathway Ca2+,Mn2+-ATPase, hSPCA2, Has Unusual Properties and Is Expressed in the Brain
Xiang et al.
J. Biol. Chem. 2005;280:11608-11614.
ABSTRACT | FULL TEXT  

Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings
da Rocha et al.
Am. J. Neuroradiol. 2004;25:1247-1250.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.